Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-30 4:20 pm Sale |
2023-03-24 | 13D | Acer Therapeutics Inc. ACER |
TVM Life Science Ventures VI LP | 1,697,709 7.200% |
-974,600 (-36.47%) |
Filing |
| 2023-02-14 4:56 pm Purchase |
2022-12-31 | 13G | Acer Therapeutics Inc. ACER |
Nantahala Capital Management, LLC | 1,226,191 7.500% |
324,901 (+36.05%) |
Filing History |
| 2022-12-02 4:02 pm Purchase |
2022-11-29 | 13D | Acer Therapeutics Inc. ACER |
Schelling Chris | 2,858,995 16.000% |
907,626 (+46.51%) |
Filing History |
| 2022-02-14 08:00 am Sale |
2021-12-31 | 13G | Acer Therapeutics Inc. ACER |
Nantahala Capital Management, LLC | 901,290 6.300% |
-88,465 (-8.94%) |
Filing History |
| 2021-02-12 3:24 pm Sale |
2020-12-31 | 13G | Acer Therapeutics Inc. ACER |
Nantahala Capital Management, LLC | 989,755 8.100% |
-900 (-0.09%) |
Filing History |
| 2020-08-06 11:43 am Purchase |
2020-07-22 | 13G | Acer Therapeutics Inc. ACER |
HIRSCHMAN ORIN | 982,446 11.000% |
430,406 (+77.97%) |
Filing History |
| 2020-08-03 4:06 pm Purchase |
2020-07-24 | 13D | Acer Therapeutics Inc. ACER |
Schelling Chris | 1,951,369 17.300% |
201,369 (+11.51%) |
Filing History |
| 2020-05-19 08:49 am Purchase |
2020-05-14 | 13G | Acer Therapeutics Inc. ACER |
HIRSCHMAN ORIN | 552,040 11.000% |
552,040 (New Position) |
Filing History |